Graviti Pharmaceuticals Private Limited recalls
2 notices naming Graviti Pharmaceuticals Private Limited as the recalling firm, since October 29, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Graviti Pharmaceuticals Private Limited: Furosemide Tablets
Hazard (FDA): Presence of Foreign Substance
FDAMedicines
Graviti Pharmaceuticals Private Limited: Bupropion Hydrochloride Extended-Release Tablets USP
Hazard (FDA): Failed Tablet/Capsule Specifications
FDAMedicines